23554803

Sirdah MM

2013

Etiological risk factors for subfertility among Palestinian women in Gaza.

23555555

Masszi G

2013

Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).

23557757

Marsh CA

2013

Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study.

23557762

Kalra SK

2013

Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate.

23557763

Wang ET

2013

Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study.

23557988

Panidis D

2013

The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.

23563463

Okohue JE

2013

Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.

23564192

El-Mesallamy H

2013

Impact of angiotensin II type 1 receptor gene polymorphism on insulin resistance in polycystic ovary syndrome.

23564759

Hansen J

2013

Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation.

23565440

Gill H

2012

Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study.

23565653

V?lez LM

2013

The biology of the peroxisome proliferator-activated receptor system in the female reproductive tract.

23566682

Pouly JL

2013

[Ovarian drilling by fertiloscopy: feasibility, results and predictive values].

23569137

Skvarca A

2013

Adiponectin/leptin ratio and insulin resistance in pregnancy.

23571154

Jeon YE

2013

Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome.

23575700

Ant?nio FI

2013

Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome.

23576169

Jansen T

2013

[Acne tarda. Acne in adults].

23577416

Fleming R

2005

Recruitment prior to ovarian stimulation: ways of improving follicular recruitment.

23577418

Tauchert S

2005

Treatment strategies in PCOS patients.

23579187

Recabarren MP

2013

Pituitary and testis responsiveness of young male sheep exposed to testosterone excess during fetal development.

23580001

Zheng J

2013

The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.

23582439

Nahuis MJ

2013

The basic fertility workup in women with polycystic ovary syndrome: a systematic review.

23582591

Schapiro NA

2013

Endocrine abnormalities. Foreword.

23582592

Kansra AR

2013

PCOS: perspectives from a pediatric endocrinologist and a pediatric gynecologist.

23585246

Oh JY

2013

The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome.

23585337

Shan Y

2013

Coagulation and fibrinolytic indices during the first trimester of pregnancy in women with polycystic ovary syndrome: a preliminary study.

23585338

Raja-Khan N

2014

The role of TGF-? in polycystic ovary syndrome.

23585659

Pavone ME

2013

Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation.

23590604

Koz?owska A

2013

The noradrenergic innervation and steroidogenic activity of porcine cystic ovaries.

23592224

Amato MC

2013

Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.

23595973

Carvajal R

2013

Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.

23595974

Carmina E

2013

Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.

23596136

Di Sarra D

2013

Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism.

23598873

Lin W

2013

[Expression of steroidogenic enzymes in the rat model of polycystic ovary syndrome].

23599814

Baculescu N

2013

The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS.

23603633

Huang X

2013

Differences in the transcriptional profiles of human cumulus cells isolated from MI and MII oocytes of patients with polycystic ovary syndrome.

23604095

Kaygusuz I

2013

Is polycystic ovarian syndrome a risk factor for urolithiasis?

23605101

Ting W

2013

The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome.

23605170

Hosseini MA

2013

Metformin treatment in different phenotypes of polycystic ovary syndrome.

23605819

Lucena E

2013

Granulocyte colony-stimulating factor (G-CSF): a mediator in endometrial receptivity for a patient with polycystic ovary (PCO) undergoing in vitro maturation (IVM).

23608312

S?godi L

2013

[Role of genetic and environmental factors in the development of polycystic ovary syndrome].

23608322

Al-Nozha O

2013

Body weight reduction and metformin: Roles in polycystic ovary syndrome.

23608780

Kedem A

2013

What is the optimal threshold of serum Anti-M?llerian hormone (AMH) necessary for IVM treatments?

23612476

Rizzo M

2013

Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome.

23612996

Nohara K

2013

Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice.

23613607

Son KH

2013

Association between fasting blood glucose and carotid intima-media thickness of polycystic ovary syndrome patients with normal glucose tolerance.

23614677

Anagnostou E

2013

The impact of genetics profile (gene polymorphisms) in obese non-PCOS women entering an IVF/ICSI program.

23616186

Grolmusz VK

2013

Lack of association between C385A functional polymorphism of the fatty acid amide hydrolase gene and polycystic ovary syndrome.

23616591

Hackbart KS

2013

Effect of glucocorticoid-induced insulin resistance on follicle development and ovulation.

23619436

Madnani N

2013

Polycystic ovarian syndrome.

23619449

Abdullah Z

2013

Hormonal profile and polycystic ovaries in women with acne vulgaris.

23621938

Reverchon M

2013

[Adiponectin and resistin: a role in the reproductive functions?].

23624028

Dumesic DA

2013

Cancer risk and PCOS.

23624030

Zhao Y

2013

Ethnic differences in the phenotypic expression of polycystic ovary syndrome.

23624031

Hsu MI

2013

Changes in the PCOS phenotype with age.

23624032

Hardy TS

2013

Diagnosis of adolescent polycystic ovary syndrome.

23624033

Bozdag G

2013

Interventions for the metabolic dysfunction in polycystic ovary syndrome.

23624351

Dokras A

2013

Cardiovascular disease risk in women with PCOS.

23624582

Lainas GT

2013

Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.

23625194

Panidis D

2013

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

23627969

van Houten EL

2013

Bone morphogenetic proteins and the polycystic ovary syndrome.

23627982

Katsiki N

2014

Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.

23628801

Zhang T

2013

Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: a systemic review and meta-analysis.

23633552

Amiot C

2013

Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry.

23636445

Helseth R

2013

Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria.

23640431

Marci R

2013

GnRH antagonists in assisted reproductive techniques: a review on the Italian experience.

23642453

Nader S

2013

Hyperandrogenism during puberty in the development of polycystic ovary syndrome.

23643846

Carmina E

2013

Introduction to the special issue: 2012 AE-PCOS meeting.

23644117

Chen X

2013

[Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].

23646492

Su D

2013

[Advance in treatment of polycystic ovary syndrome].

23653271

Kozakowski J

2013

Body composition, glucose metabolism markers and serum androgens - association in women with polycystic ovary syndrome.

23653275

Zachurzok A

2013

Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy.

23653278

Pujanek M

2013

Pathomechanisms of the development of obesity in some endocrinopathies - an overview.

23656383

Pau CT

2013

Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome.

23659986

Wang J

2013

The association between polycystic ovary syndrome and ectopic pregnancy after in vitro fertilization and embryo transfer.

23661022

Xu P

2013

The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population.

23663009

Oh JY

2014

Clinical implications of menstrual cycle length in oligomenorrhoeic young women.

23665441

Kanaya N

2013

Androgen (dihydrotestosterone)-mediated regulation of food intake and obesity in female mice.

23666047

Wu D

2013

Intake of vinegar beverage is associated with restoration of ovulatory function in women with polycystic ovary syndrome.

23666971

Sang Q

2013

Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo.

23672289

Tar?n JJ

2013

Endocrinology and physiology of pseudocyesis.

23675970

Hossain MM

2013

Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model.

23676106

Zheng YH

2013

Effectiveness of abdominal acupuncture for patients with obesity-type polycystic ovary syndrome: a randomized controlled trial.

23678035

Michael AE

2013

Ovarian 11?-hydroxysteroid dehydrogenase (11?HSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens.

23678455

Farzadi L

2012

Evaluation of ovarian reserve after laparoscopic surgery in patients with polycystic ovary syndrome.

23681867

Sam AH

2013

Recent advancements in the drug treatment of endocrine diseases.

23683256

Su WH

2013

Recurrent pregnancy loss and thrombophilia in women with PCOS.

23683262

Kazerooni T

2013

Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: a comparative study.

23683310

Shayeb AG

2014

Birth weight and ovulatory dysfunction.

23683504

Franks S

2013

Polycystic ovary syndrome. Preface.

23684116

Tal R

2013

Transforming growth factor-?1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.

23685132

Masszi G

2013

Endothelial relaxation mechanisms and nitrative stress are partly restored by Vitamin D3 therapy in a rat model of polycystic ovary syndrome.

23685395

Sobotka V

2014

Steroids pretreatment in assisted reproduction cycles.

23685884

Radavelli-Bagatini S

2013

Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome.

23686705

Ouyang JX

2013

RNA interference mediated pten knock-down inhibit the formation of polycystic ovary.

23688000

Musmar S

2013

Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine.

23688334

Jakubowicz D

2013

Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome.

23688663

Chan WP

2013

Premature aging of cardiovascular/platelet function in polycystic ovarian syndrome.

23689174

Ghasemi M

2013

The cycle characteristics of clomiphene with clomiphene and menotropins in polycystic ovary syndrome and non polycystic ovary syndrome infertile patients.

23690166

Lin SL

2013

Lower expression of ER-?36 is associated with the development of endometrial hyperplasia in PCOS patients.

23690338

Moro F

2013

Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.